Who Attends

Interdisciplinary & Interconnected

More than 1,200 attendees are expected to attend the 2015 World Stem Cell Summit & RegMed Capital Conference from 40 countries+. Prominent industry leaders, scientists, clinicians, venture capitalists, angel investors, philanthropists, regulators, policymakers, patient advocates, economic development officers and experts in law and ethics join together to advance our field.

Attendee Distribution



Who Attends the World Stem Cell Summit & RegMed Capital Confernce:

2010 World Stem Cell Summit AudienceTherapeutic and Enabling Products & Technology
academic investigators
biotechnology and pharmaceutical companies
cord blood banks
cell therapy companies
gene therapy companies
medical device companies
platform technology, equipment manufacturers & suppliers
reagents & materials suppliers
tissue engineering companies

Contract Service Providers
contract manufacturing organizations (CMO) – GMP, GTP
contract research organizations (CRO)
contract testing laboratories
law firms
tissue procurement organizations, cell collection services
transportation & logistics services, cell banking services

Academic & Government Institutions
cell therapy, gene therapy & tissue engineering programs
clinical centers & hospitals
funding agencies
policy makers, government leaders
stem cell network leaders
technology transfer staff

Investors, Analysts & Business Developers

board members
economic development offices
insurance companies
investors/financial analysts
law firms
national investment departments
technology transfer staff

Regulatory & Policy Agencies
IRB, ESCRO & SCRO committee members
law firms
national & international regulators – FDA, EMA, etc

Patient Advocacy Organizations, Patient Advocates & Clinicians
advocacy organizations
patients & patients’ families

Science and Medical Journalists